- Home
- GSK vs TDG Comparison
GSK vs TDG Comparison
Compare GSK & TDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- TDG
- Stock Information
- Founded
- GSK 1715
- TDG 1993
- Country
- GSK United Kingdom
- TDG United States
- Employees
- GSK N/A
- TDG N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- TDG Military/Government/Technical
- Sector
- GSK Health Care
- TDG Industrials
- Exchange
- GSK Nasdaq
- TDG Nasdaq
- Market Cap
- GSK 77.1B
- TDG 78.3B
- IPO Year
- GSK N/A
- TDG 2006
- Fundamental
- Price
- GSK $40.85
- TDG $1,271.37
- Analyst Decision
- GSK Hold
- TDG Buy
- Analyst Count
- GSK 2
- TDG 13
- Target Price
- GSK N/A
- TDG $1,615.85
- AVG Volume (30 Days)
- GSK 3.8M
- TDG 403.6K
- Earning Date
- GSK 10-29-2025
- TDG 11-06-2025
- Dividend Yield
- GSK 3.96%
- TDG 5.90%
- EPS Growth
- GSK N/A
- TDG 11.52
- EPS
- GSK 1.13
- TDG 30.14
- Revenue
- GSK $43,336,073,439.00
- TDG $8,580,000,000.00
- Revenue This Year
- GSK $5.66
- TDG $11.96
- Revenue Next Year
- GSK $5.13
- TDG $9.99
- P/E Ratio
- GSK $17.49
- TDG $42.19
- Revenue Growth
- GSK 0.59
- TDG 12.81
- 52 Week Low
- GSK $31.72
- TDG $1,183.60
- 52 Week High
- GSK $43.62
- TDG $1,623.83
- Technical
- Relative Strength Index (RSI)
- GSK 59.28
- TDG 31.24
- Support Level
- GSK $39.37
- TDG $1,275.14
- Resistance Level
- GSK $41.53
- TDG $1,324.88
- Average True Range (ATR)
- GSK 0.61
- TDG 29.77
- MACD
- GSK 0.11
- TDG -2.61
- Stochastic Oscillator
- GSK 76.38
- TDG 15.13
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About TDG Transdigm Group Incorporated
TransDigm manufactures and services a broad set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses its portfolio on firms that make proprietary aerospace products with substantial aftermarket demand. TransDigm regularly employs financial leverage to amplify its operating results.